Sex Differences in Age at Primary Melanoma Diagnosis in a Population-Based Analysis (US Surveillance, Epidemiology, and End Results, 2005-2011)

Affiliations

¹ Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. Electronic address: jnajita@jimmy.harvard.edu.
² Department of Dermatology, Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute, Stanford, California, USA; Dermatology Service, VA Palo Alto Health Care System, Palo Alto, California, USA.
³ Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
⁴ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
⁵ Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
⁶ Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts, USA.

Julie S Najita et al. J Invest Dermatol. 2016 Sep.

. 2016 Sep;136(9):1894-1897.

doi: 10.1016/j.jid.2016.03.044. Epub 2016 May 29.

¹ Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. Electronic address: jnajita@jimmy.harvard.edu.
² Department of Dermatology, Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute, Stanford, California, USA; Dermatology Service, VA Palo Alto Health Care System, Palo Alto, California, USA.
³ Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
⁴ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
⁵ Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
⁶ Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts, USA.

No abstract available

Conflict of interest statement

CONFLICT OF INTEREST

The authors state no conflict of interest.

1. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–206. - PMC - PubMed
1. Balch CM, Thompson JF, Gershenwald JE, Soong SJ, Ding S, McMasters KM, et al. Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients. Ann Surg Oncol. 2014;21:1075–81. - PMC - PubMed
1. Geller AC, Johnson TM, Miller DR, Brooks KR, Layton CJ, Swetter SM. Factors associated with physician discovery of early melanoma in middle-aged and older men. Arch Dermatol. 2009;145:409–14. - PubMed
1. Green A. A theory of site distribution of melanomas: Queensland, Australia. Cancer Causes Control. 1992;3:513–6. - PubMed
1. Hsiao CJ, Cherry DK, Beatty PC, Rechtsteiner EA. National ambulatory medical care survey: 2007 summary. Natl Health Stat Report. 2010;27:1–32. - PubMed